ET Healthcare (Suzhou) Co., LTDH7.A77ET Healthcare is a cutting-edge company specializing in in vitro diagnostics, founded in Silicon Valley by Dr. Hong Tan and Bob Zuk in 2012. With research and development facilities in both the United States and China, our manufacturing site is currently located in Suzhou, China.
Dr. Tan and Bob Zuk are the pioneers behind the Bio-Layer Interferometry (BLI) technology, which was introduced in 2001 and has since been widely adopted in the life sciences as a label-free optical detection technology. This technology was officially recognized in the 2021 edition of the United States Pharmacopoeia. Building on this success, they continued to innovate and developed the cyclic enhanced fluorescence immunoassay, which has been applied in in-vitro diagnostics. This led to the birth of ET Healthcare, which has now established itself as a leading brand in outpatient clinics and emergency departments in China.
ET Healthcare boasts over 2000 installations in China, offering a wide range of tests covering areas such as cardiorenal function, inflammation, gastric function, hormones, thrombosis and hemostasis, and brain injury. The number of hospitals using the Pylon platform for external quality assessment has grown at a compound annual growth rate (CAGR) exceeding 50% over the past four years.
As a member of The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and the Cardiac Marker Committee, ET Healthcare has installations in some of the top cardiovascular hospitals in China.
